Concordance between clinical outcomes in the Systolic Blood Pressure Intervention Trial and in the electronic health record
Contemporary Clinical Trials · 2023
DOI: 10.1016/j.cct.2023.107172 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2023. Verfasst von Chi D Chu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California, San Francisco, San Francisco, CA, United States of America. Electronic address: Chi.Chu@ucsf.edu. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Cardiovascular Diseases, Heart Failure, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AHRQ HHS, NIDDK NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Randomized trials are the gold standard for generating clinical practice evidence, but follow-up and outcome ascertainment are resource-intensive. Electronic health record (EHR) data from routine care can be a cost-effective means of follow-up, but concordance with trial-ascertained outcomes is less well-studied. METHODS: We linked EHR and trial data for participants of the Systolic Blood Pressure Intervention Trial (SPRINT), a randomized trial comparing intensive and standard blood pressure targets. Among participants with available EHR data concurrent to trial-ascertained outcomes, we calculated sensitivity, specificity, positive predictive value, and negative predictive value for EHR-recorded cardiovascular disease (CVD) events, using the gold standard of SPRINT-adjudicated outcomes (myocardial infarction (MI)/acute coronary syndrome (ACS), heart failure, stroke, and composite CVD events). We additionally compared the incidence of non-CVD adverse events (hyponatremia, hypernatremia, hypokalemia, hyperkalemia, bradycardia, and hypotension) in trial versus EHR data. RESULTS: 2468 SPRINT participants were included (mean age 68 (SD 9) years; 26% female). EHR data demonstrated ≥80% sensitivity and specificity, and ≥ 99% negative predictive value for MI/ACS, heart failure, stroke, and composite CVD events. Positive predictive value ranged from 26% (95% CI; 16%, 38%) for heart failure to 52% (95% CI; 37%, 67%) for MI/ACS. EHR data uniformly identified more non-CVD adverse events and higher incidence rates compared with trial ascertainment. CONCLUSIONS: These results support a role for EHR data collection in clinical trials, particularly for capturing laboratory-based adverse events. EHR data may be an efficient source for CVD outcome ascertainment, though there is clear benefit from adjudication to avoid false positives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of California, San Francisco, San Francisco, CA, United States of America. Electronic address: Chi.Chu@ucsf.edu.
- Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, United States of America.
- Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, United States of America.
- Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, MI, United States of America.
- Division of Nephrology & Hypertension, University of Utah Health, Salt Lake City, UT, United States of America.
- Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
Förderung
- AHRQ HHS
- NIDDK NIH HHS
- NCATS NIH HHS
- NHLBI NIH HHS
- Agency for Healthcare Research and Quality
- National Center for Advancing Translational Sciences
- National Institutes of Health
- National Heart, Lung, and Blood Institute
Zitieren
APA
Chu, C. D., Lenoir, K. M., Rai, N. K., Soman, S., Dwyer, J. P., Rocco, M. V., Agarwal, A. K., Beddhu, S., Powell, J. R., Suarez, M. M., Lash, J. P., McWilliams, A., Whelton, P. K., Drawz, P. E., Pajewski, N. M., Ishani, A., & Tuot, D. S. (2023). Concordance between clinical outcomes in the Systolic Blood Pressure Intervention Trial and in the electronic health record. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2023.107172
Vancouver
Chu CD, Lenoir KM, Rai NK, Soman S, Dwyer JP, Rocco MV, et al. Concordance between clinical outcomes in the Systolic Blood Pressure Intervention Trial and in the electronic health record. Contemporary Clinical Trials. 2023. doi:10.1016/j.cct.2023.107172
BibTeX
@article{Chu2023,
author = {Chu, Chi D and Lenoir, Kristin M and Rai, Nayanjot Kaur and Soman, Sandeep and Dwyer, Jamie P and Rocco, Michael V and Agarwal, Anil K and Beddhu, Srinivasan and Powell, James R and Suarez, Maritza M and Lash, James P and McWilliams, Andrew and Whelton, Paul K and Drawz, Paul E and Pajewski, Nicholas M and Ishani, Areef and Tuot, Delphine S},
title = {Concordance between clinical outcomes in the Systolic Blood Pressure Intervention Trial and in the electronic health record},
journal = {Contemporary Clinical Trials},
year = {2023},
doi = {10.1016/j.cct.2023.107172}
}
EUVIMED